Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients
Evaluation of a Virtual Reality-Directed Brain Gut Behavioral Treatment Inpatient Program for Patients With Inflammatory Bowel Disease
University of Michigan
40 participants
Feb 13, 2024
INTERVENTIONAL
Conditions
Summary
The research is studying virtual reality (VR)-directed brain-gut behavioral therapy (BGBT) as a pain treatment option for hospitalized patients with inflammatory bowel disease (IBD). This study is being done to learn if VR-directed BGBT is feasible and acceptable for patients with IBD in addressing pain in the hospital setting. The study hypothesizes that: * At least 75% of enrolled participants will complete the VR-directed BGBT inpatient program * Hospitalized patients with IBD will find VR-directed BGBT acceptable as a pain treatment option in the inpatient setting.
Eligibility
Inclusion Criteria2
- Patients with Inflammatory Bowel Disease and self-reported pain
- Hospitalized for management of IBD (inpatient medicine services at Michigan Medicine)
Exclusion Criteria6
- Patients that do not report pain
- Anticipated length of hospital stay is less than 72 hours
- Patients that have previously had a seizure, loss of awareness, or other symptoms linked to an epileptic condition
- Patients with binocular vision loss
- Patients with an uncontrolled cardiac condition such as an arrhythmia, coronary artery disease, or neurological/cerebrovascular disease.
- Patients that are currently pregnant
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Enrolled participants will receive up to 3-days of VR-directed BGBT through several modules including distraction games, mindfulness meditation, breathing exercises, and cognitive behavioral therapy based coaching. Participants will complete questionnaires at various time points and be asked to complete a semi-structured interview post-intervention.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06188793